These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9645617)

  • 21. High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis.
    He YW; Bevan MJ
    J Exp Med; 1999 Dec; 190(12):1903-8. PubMed ID: 10601365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for CD43 function.
    Walker J; Green JM
    J Immunol; 1999 Apr; 162(7):4109-14. PubMed ID: 10201935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CBF.78 monoclonal antibody to human sialophorin has distinct properties giving new insights into the CD43 marker and its activation pathway.
    Tkaczuk J; Al Saati T; Escargueil-Blanc I; Salvayre A; Horejsi V; Durand M; de Preval C; Ohayon E; Delsol G; Abbal M
    Tissue Antigens; 1999 Jul; 54(1):1-15. PubMed ID: 10458318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD43 polarization in unprimed T cells can be dissociated from raft coalescence by inhibition of HMG CoA reductase.
    Gubina E; Chen T; Zhang L; Lizzio EF; Kozlowski S
    Blood; 2002 Apr; 99(7):2518-25. PubMed ID: 11895788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome.
    Siminovitch KA; Greer WL; Axelsson B; Rubin LA; Novogrodsky A; Peacocke M
    Immunodeficiency; 1993; 4(1-4):99-108. PubMed ID: 8167744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD43 potentiates CD3-induced proliferation of murine intestinal intraepithelial lymphocytes.
    Bagriacik EU; Tang M; Wang HC; Klein JR
    Immunol Cell Biol; 2001 Jun; 79(3):303-7. PubMed ID: 11380685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line.
    Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF
    J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis.
    McFarland TA; Ardman B; Manjunath N; Fabry JA; Lieberman J
    J Immunol; 1995 Feb; 154(3):1097-104. PubMed ID: 7822786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD43 deficiency has no impact in competitive in vivo assays of neutrophil or activated T cell recruitment efficiency.
    Carlow DA; Ziltener HJ
    J Immunol; 2006 Nov; 177(9):6450-9. PubMed ID: 17056577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
    Ardman B; Sikorski MA; Settles M; Staunton DE
    J Exp Med; 1990 Oct; 172(4):1151-8. PubMed ID: 1976735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent superphosphorylation of leukosialin (CD43) in activated T cells and in tumour cell lines.
    Axelsson B; Perlmann P
    Scand J Immunol; 1989 Nov; 30(5):539-47. PubMed ID: 2531463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of immature dendritic cells via membrane sialophorin (CD43).
    Fanales-Belasio E; Zambruno G; Cavani A; Girolomoni G
    Adv Exp Med Biol; 1997; 417():207-12. PubMed ID: 9286363
    [No Abstract]   [Full Text] [Related]  

  • 33. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin.
    Delon J; Kaibuchi K; Germain RN
    Immunity; 2001 Nov; 15(5):691-701. PubMed ID: 11728332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD43 interferes with T-lymphocyte adhesion.
    Ardman B; Sikorski MA; Staunton DE
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):5001-5. PubMed ID: 1594606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
    Giordanengo V; Limouse M; Desroys du Roure L; Cottalorda J; Doglio A; Passeron A; Fuzibet JG; Lefebvre JC
    Blood; 1995 Sep; 86(6):2302-11. PubMed ID: 7662977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin.
    Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V
    Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted disruption of CD43 gene enhances T lymphocyte adhesion.
    Manjunath N; Johnson RS; Staunton DE; Pasqualini R; Ardman B
    J Immunol; 1993 Aug; 151(3):1528-34. PubMed ID: 8335945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced susceptibility to human immunodeficiency virus infection in CD4+ T lymphocytes genetically deficient in CD43.
    Srinivas RV; Su T; Trimble LA; Lieberman J; Ardman B
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1015-21. PubMed ID: 8554898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell activation in the curious world of the intestinal intraepithelial lymphocyte.
    Klein JR
    Immunol Res; 2004; 30(3):327-37. PubMed ID: 15531773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.